SCHEMBL1972194

SCHEMBL1972194

O=C(Cl)c1cccnc1Br

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.47
LMNA P02545 1/20 0.47
KDM4E B2RXH2 3/20 0.45
TDP1 Q9NUW8 1/20 0.45
ALDH1A1 P00352 3/20 0.44
ALOX15 P16050 2/20 0.44
CYP3A4 P08684 1/20 0.44
MAPT P10636 1/20 0.44
TSHR P16473 1/20 0.44
BLM P54132 1/20 0.44
AGER Q15109 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
TRIM24 O15164 1/20 0.44
TRIM33 Q9UPN9 1/20 0.44
NAPRT Q6XQN6 2/20 0.42
P2RX7 Q99572 1/20 0.42
MEN1 O00255 1/20 0.40
PSMD14 O00487 1/20 0.40
NPC1 O15118 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL17541418 0.98 SMN1; SMN2 (0.46) SMN1; SMN2LMNAKDM4ETDP1ALDH1A1
SCHEMBL932828 0.81 KDM4E (0.63) SMN1; SMN2LMNAKDM4ETDP1ALDH1A1
SCHEMBL29442955 0.81 KDM4E (0.63) SMN1; SMN2LMNAKDM4ETDP1ALDH1A1
SCHEMBL30040285 0.79 PARP1 (0.56) SMN1; SMN2LMNAKDM4ETDP1ALDH1A1
SCHEMBL1379678 0.79 PARP1 (0.56) SMN1; SMN2LMNAKDM4ETDP1ALDH1A1
Hydrochloric Acid SCHEMBL10560254 0.79 KDM4E (0.61) SMN1; SMN2LMNAKDM4ETDP1ALDH1A1
SCHEMBL365580 0.79 KDM4E (0.45) SMN1; SMN2LMNAKDM4ETDP1ALDH1A1
SCHEMBL30320721 0.79 KDM4E (0.45) SMN1; SMN2LMNAKDM4ETDP1ALDH1A1
SCHEMBL22395413 0.79 P2RX7 (0.64) KDM4ETDP1ALDH1A1CYP3A4NAPRT
SCHEMBL1427354 0.79 LMNA (0.43) SMN1; SMN2LMNAKDM4ETDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118271285-A Azetidine-containing amide derivative, preparation method and application thereof 贵州大学 2024-07-02 CN disclosed
CN-116874441-A Flexible aryl formamide derivative containing 1,2, 4-oxadiazole as well as preparation method and application thereof 贵州大学 2023-10-13 CN disclosed
CN-116410129-A Nevirapine intermediate compound 山东新时代药业有限公司 2023-07-11 CN disclosed
EP-3190888-B1 PROBES FOR IMAGING HUNTINGTIN PROTEIN CHDI FOUNDATION INC (US) 2020-06-10 EP disclosed
CN-107531641-A Oxazoline ring-containing compound, material for electron transport/injection layer containing the same, and organic electroluminescent element using the same 捷恩智株式会社 2018-01-02 CN disclosed
US-20170292150-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN CHDI FOUNDATION, INC. 2017-10-12 US disclosed
US-20170292150-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN CHDI FOUNDATION, INC. 2017-10-12 US disclosed
WO-2016033460-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN CHDI FOUNDATION, INC. (US) 2016-03-03 WO disclosed
US-8846920-B2 Metal complexes MERCK PATENT GMBH (DE) 2014-09-30 US disclosed
EP-2535327-A1 Insecticidal 3-acylaminobenzanilides Bayer CropScience AG (DE) 2012-12-19 EP disclosed
EP-1912933-A1 INSECTICIDAL 3-ACYLAMINOBENZANILIDES Bayer CropScience AG (DE) 2008-04-23 EP disclosed
WO-2007051560-A1 INSECTICIDAL 2 -ACYLAMINOTHIAZOLE-4 -CARBOXAMIDES BAYER CROPSCIENCE AG (DE) 2007-05-10 WO disclosed
US-20070034863-A1 fac-tris[7,7-difluoro-7H-dibenzo[de,h]quinoline-C2,N]iridium(III) (Ir1)A: 7,7-Difluorodibenzo[de,h]quinoline; use in organic electronic devices such as electroluminescent elements, and to their use in displays based thereon UDC IRELAND LIMITED (IE) 2007-02-15 US disclosed
WO-2007017075-A1 INSECTICIDAL 3-ACYLAMINOBENZANILIDES BAYER CROPSCIENCE AG (DE) 2007-02-15 WO disclosed
EP-1675929-A1 METAL COMPLEXES MERCK PATENT GmbH (DE) 2006-07-05 EP disclosed
WO-2005033244-A1 METAL COMPLEXES COVION ORGANIC SEMICONDUCTORS GMBH (DE) 2005-04-14 WO disclosed
US-RE32975-E FUNGICIDES, BACTERICIDES, FEED ADDITIVES BAYER AKTIENGESELLSCHAFT (DE) 1989-07-04 US disclosed
EP-0004279-B1 PROCESS FOR THE PREPARATION OF 4-PYRIDONE-3-CARBOXYLIC ACIDS, 1-CYCLOPROPYL-4-PYRIDONE-3-CARBOXYLIC ACID DERIVATIVES AND MEDICINES CONTAINING THEM BAYER AG (DE) 1982-12-29 EP disclosed
US-4284629-A ANIMAL GROWTH REGULATORS BAYER AKTIENGESELLSCHAFT (DE) 1981-08-18 US disclosed
EP-0004279-A1 Process for the preparation of 4-pyridone-3-carboxylic acids, 1-cyclopropyl-4-pyridone-3-carboxylic acid derivatives and medicines containing them BAYER AG (DE) 1979-10-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070034863-A1 fac-tris[7,7-difluoro-7H-dibenzo[de,h]quinoline-C2,N]iridium(III) (Ir1)A: 7,7-Difluorodibenzo[de,h]quinoline; use in organic electronic devices such as electroluminescent elements, and to their use in displays based thereon NISCH, CISD1, AFF1 SMN1; SMN2 4196/4885LMNA 4698/4885KDM4E 3959/4885
US-20170292150-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN HTT, HYPK, FABP7 SMN1; SMN2 94/4885LMNA 1795/4885KDM4E 4674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.